Equitable Trust Co. decreased its holdings in shares of HCA Healthcare Inc (NYSE:HCA) by 13.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 95,486 shares of the company’s stock after selling 15,100 shares during the period. HCA Healthcare comprises approximately 1.4% of Equitable Trust Co.’s holdings, making the stock its 16th largest position. Equitable Trust Co.’s holdings in HCA Healthcare were worth $12,907,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of HCA. Magellan Asset Management Ltd boosted its holdings in HCA Healthcare by 21.0% in the 2nd quarter. Magellan Asset Management Ltd now owns 15,621,068 shares of the company’s stock worth $2,111,500,000 after buying an additional 2,712,130 shares during the period. Amundi Pioneer Asset Management Inc. boosted its holdings in shares of HCA Healthcare by 2.3% during the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 1,290,505 shares of the company’s stock valued at $168,257,000 after purchasing an additional 28,925 shares during the last quarter. Ballentine Partners LLC bought a new position in shares of HCA Healthcare during the 1st quarter valued at about $209,000. Burney Co. boosted its holdings in shares of HCA Healthcare by 2.2% during the 1st quarter. Burney Co. now owns 79,903 shares of the company’s stock valued at $10,418,000 after purchasing an additional 1,751 shares during the last quarter. Finally, Granite Investment Partners LLC bought a new position in shares of HCA Healthcare during the 1st quarter valued at about $358,000. 70.19% of the stock is owned by hedge funds and other institutional investors.
Shares of NYSE HCA traded down $1.79 during mid-day trading on Wednesday, hitting $119.50. 572,894 shares of the company’s stock traded hands, compared to its average volume of 1,382,136. The company’s 50-day moving average is $124.25 and its two-hundred day moving average is $128.43. The company has a market capitalization of $42.38 billion, a P/E ratio of 12.23, a PEG ratio of 1.06 and a beta of 0.87. HCA Healthcare Inc has a 1 year low of $110.31 and a 1 year high of $147.42.
The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Tuesday, September 3rd will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.34%. The ex-dividend date is Friday, August 30th. HCA Healthcare’s dividend payout ratio is 16.38%.
In related news, SVP Robert A. Waterman sold 33,786 shares of the stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $134.98, for a total value of $4,560,434.28. Following the sale, the senior vice president now directly owns 279,551 shares of the company’s stock, valued at approximately $37,733,793.98. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Kathleen M. Whalen sold 977 shares of the stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $127.56, for a total transaction of $124,626.12. Following the completion of the sale, the senior vice president now directly owns 11,484 shares in the company, valued at $1,464,899.04. The disclosure for this sale can be found here. Corporate insiders own 2.70% of the company’s stock.
Several research analysts have commented on the stock. Stephens set a $150.00 price objective on shares of HCA Healthcare and gave the company a “buy” rating in a report on Wednesday, August 7th. UBS Group increased their price objective on shares of HCA Healthcare from $172.00 to $181.00 and gave the company a “buy” rating in a report on Monday, June 24th. ValuEngine downgraded shares of HCA Healthcare from a “hold” rating to a “sell” rating in a report on Tuesday, September 17th. Mizuho set a $153.00 price objective on shares of HCA Healthcare and gave the company a “buy” rating in a report on Wednesday, July 31st. Finally, Goldman Sachs Group raised shares of HCA Healthcare from a “neutral” rating to a “buy” rating and increased their price objective for the company from $147.00 to $160.00 in a report on Wednesday, July 10th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and fourteen have given a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $155.63.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Recommended Story: Forex
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.